NASDAQ:DSGN | Cash Flow Statement | Design Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$20.17M
2026-03-31-$17.64M-$16.43M$0.00-$7.59M$19.93M
2025-12-31-$16M-$11.97M$34,000.00-$11.58M$25.32M
2025-09-30-$17M
2025-06-30-$19.08M
2025-03-31-$17.72M-$16.79M$72,000.00$7.87M$23,000.00
2024-12-31-$13.65M-$9.86M$0.00$1.83M$263,000.00
2024-09-30-$13.04M
2024-06-30-$11.79M
2024-03-31-$11.11M-$12.44M$195,000.00$20.62M$20,000.00
2023-12-31-$11.84M-$12.8M$27,000.00$5.56M$501,000.00
2023-09-30-$15.79M
2023-06-30-$19.94M
2023-03-31-$19.29M-$17.42M$87,000.00$19.73M
2022-12-31-$17.34M-$15.09M$288,000.00-$1.06M$130,000.00
2022-09-30-$17.7M
2022-06-30-$15M
2022-03-31-$13.27M-$11.83M$76,000.00$414,000.00$156,000.00
2021-12-31-$11.07M-$9.23M$354,000.00-$50.06M$193,000.00
2021-09-30-$11.32M
2021-06-30-$7.64M
2021-03-31-$5.51M-$3.7M$33,000.00$23.03M$378.98M
2020-12-31-$3.86M-$2.84M$14,000.00$2M$1,000.00
2020-09-30-$2.32M
2020-06-30-$1.44M
2020-03-31-$663,000.00-$2.66M-$39.25M$44.53M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$69.79M-$54.36M$193,000.00$22.91M$25.74M
2024-12-31-$49.59M-$43.11M$340,000.00$43.96M$513,000.00
2023-12-31-$66.86M-$58.56M$256,000.00$52.54M$724,000.00
2022-12-31-$63.31M-$51.32M$918,000.00-$220.99M$235,000.00
2021-12-31-$35.53M-$29.38M$1.54M-$53.64M$379.21M
2020-12-31-$8.28M-$8.67M$76,000.00-$33.56M$44.53M